"We are very hopeful that over time, the program is going to grow and its going to be a huge success," said Cat Stewart, senior director of outreach and education for Cresco Labs, a large grower in Illinois. "We have 39 conditions approved now and, yes, another eight were just rejected in January. We aren't going to stop fighting for patients' rights to join this program."